Sachdev, J.C., Snider, J.N., Allen, J.W., Schwartzberg, L.S., Young, R.R., Javed, A.Y., Smeltzer, M.P., Yunus, F., Verrier, C.S. and Jahanzeb, M. 1. NEOADJUVANT WEEKLY NAB-PACLITAXEL PLUS CARBOPLATIN FOLLOWED BY DOXORUBICIN PLUS CYCLOPHOSPHAMIDE WITH BEVACIZUMAB ADDED CONCURRENTLY TO CHEMOTHERAPY FOR OPERABLE TRIPLE-NEGATIVE INVASIVE BREAST CANCER. Journal of Cancer & Allied Specialties. 2, 1 (1). DOI:https://doi.org/10.37029/jcas.v2i1.59.